Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

His center is already using point-of-care ultrasound and recently had a case in which a patient who forgot and took his GLP-1 ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

Recent studies have shown that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic ...

For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 ...

and colleagues examined the impact of GLP-1 RA use on EO-CRC risk. The analysis included data from roughly 1.8 million ...

Most patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from ...

Recently the U.S. Food and Drug Administration (FDA) issued updated safety warnings for all glucagon-like peptide 1 receptor ...

The GLP-1 RA cohort had significantly lower odds of ... with a diagnosis of type 2 diabetes (subsequently prescribed antidiabetic medications) but with no prior CRC diagnosis identified from ...

A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists ... of blockbuster GLP-1 RA drugs," said senior ...